Canine tumor immunotherapy is a treatment that strengthens the immune system to recognize and attack cancer cells. Effective management and selection criteria are important.





| Item | Key points |
|---|---|
| Who leads treatment | Consult the veterinarian/oncologist who diagnosed the tumor, rather than choosing an advertised product |
| Where treatment fits | First plan whether to combine with standard treatments such as surgery, chemotherapy, and radiation |
| Supplement caution | Be wary of unproven supplements and exaggerated advertising; confirm with your veterinarian before use |
| Observation records | Record changes in appetite, weight, and energy and share them at the examination |
This is not a table recommending specific products or hospitals, but criteria to reference when consulting your veterinarian. Always make treatment and testing decisions together with your veterinarian through an examination.
Precautions and Contraindications
Immunotherapy boosts your dog’s immune response, so it must be used with particular caution in dogs with autoimmune diseases. It can also interact with other medications or supplements, so always consult your veterinarian before use. Keep in mind that immunotherapy is not effective for every dog or every type of cancer. If your dog shows loss of appetite, vomiting, or fatigue during treatment, contact your veterinarian immediately for evaluation.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Mason, N. & Dow, S. (2011) Therapeutic Strategies in Veterinary Oncology. Journal of Veterinary Internal Medicine, 25(4), 920–926.
[2] Lee, W.S. et al. (2020) Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk. Experimental & Molecular Medicine, 52(9), 1475–1485.
[3] Treggiari, E. et al. (2016) A retrospective review of outcome and survival following surgery and adjuvant xenogeneic DNA vaccination in 32 dogs with oral malignant melanoma. The Journal of Veterinary Medical Science, 78(5), 845–850.